WASHINGTON, DC – Kristin W. Weitzel, PharmD, CDE, FAPhA, has been named Editor-in-Chief of the APhA DrugInfoLine, an online publication that provides continuous drug-news updates to APhA members via the Web and mobile devices.
Weitzel began with APhA in 2012 as a Contributing Writer to ADIL, participating in idea identification and responsible for initial drafts of most articles. Her promotion to Editor-in-Chief recognizes her strengths in communicating complicated scientific studies to pharmacists in an easy-to-understand format.
As Editor-in-Chief of ADIL, Weitzel works with a team of Section Advisors who are content experts in 20 therapeutic areas, including diabetes, cardiology, immunizations, HIV, self-care, and pharmacogenomics. The Advisors approve ideas and review all articles before they are posted on the ADIL website, online at www.aphadruginfoline.com.
“We are pleased to have Kristin on the APhA periodicals team,” noted Thomas E. Menighan, BSPharm, MBA, ScD, APhA Executive Vice President and CEO. “APhA members have come to rely on ADIL for the news and updates about clinical therapeutics they need in their daily medication therapy management practices. The Board of Trustees and the APhA staff look forward to working with Kristin as she and her team maintain the high standards and utility of ADIL.”
Weitzel is Clinical Associate Professor and Associate Director of the Personalized Medicine Program at the University of Florida College of Pharmacy in Gainesville, Fla. She was formerly Associate Editor and Director of Editorial Projects at Pharmacist’s Letter/Prescriber’s Letter. An active member of APhA, Weitzel has served the Association as Member-at-Large on the APhA Academy of Pharmacy Practice and Management (APhA–APPM) Executive Committee, Chair of the APhA–APPM Clinical/Pharmacotherapeutic Section, and past member of the Community Pharmacy Residency Advisory Panel. Weitzel was named an APhA Fellow in 2009.
“ADIL meets an important need for APhA members by providing up-to-date information on drug therapy developments that affect pharmacy practice,” said Weitzel. “My goal as ADIL grows is to identify and highlight timely and relevant pharmacotherapy updates that are important to the profession. I look forward to an exciting time of finding new ways in which ADIL can meet members’ needs and engage pharmacists.”
L. Michael Posey, BSPharm, MA, Editor of ADIL since its inception in 2000 and currently Associate Vice President of Periodicals at APhA, transitions into the role of Executive Editor for the newsletter. In this capacity, Posey will manage the budget of the publication, interface with the Publisher, connect with APhA staff, assist with articles and alerts as needed, and supervise staff support of ADIL.
About the American Pharmacists Association
The American Pharmacists Association, founded in 1852 as the American Pharmaceutical Association, is a 501 (c)(6) organization, representing more than 62,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians and others interested in advancing the profession. APhA, dedicated to helping all pharmacists improve medication use and advance patient care, is the first-established and largest association of pharmacists in the United States. For more information, please visit www.pharmacist.com.